Evaluating the Clinical Efficacy of Thulio vs. Holmium Laser Enucleation of the Prostate

Study Design This is a prospective randomized study to evaluate the differences in outcomes comparing the existing laser to a new laser among patients undergoing HoLEP. Patients will be evaluated prior to the procedure and at one follow-up time point. Patients will be randomized in equal numbers to each group. The primary outcome will be non-inferiority in hemostasis timing. Several secondary outcomes will be evaluated including enucleation time, active laser time, morcellation time, prostate volume, change in hemoglobin, applied total laser energy, enucleation efficacy (g/min), IPSS (International Prostate Symptom Score), QoL (Quality of Life), uroflowmetry, PVR (post-void residual), duration of catheterization.

Inclusion criteria

• Understand and voluntarily sign an informed consent form.
• Patients must be males with a prostate, at least 18 years of age
• No prior prostate surgery

Exclusion criteria

• Unable/refuse to provide informed consent
• Prior prostate surgery
• Bladder stones that requiring lasering (small stone that can be removed whole is ok)
• Unable to hold anticoagulants or antiplatelets per standard protocols for surgery and up to 1 week postop.